Health
Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan – Yahoo Finance
Moderna announces New Drug Application submitted to import and distribute Moderna’s COVID-19 vaccine candidate in Japan.
50 million doses of Modernas COVID-19 vaccine candidate expected to be distributed beginning in the first half of 2021, pending licensure in Japan
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application to the Government of Japans Ministry of Health, Labour and Welfare (MHLW) to import and distribute Modernas vaccine candidate against COVID-19…
-
General21 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
General19 hours agoIslam Makhachev claims UFC welterweight belt with dominant win over Jack Della Maddalena
-
Noosa News9 hours agoGovernment auditors suspected lab was conducting shonky tests on infrastructure projects
-
Noosa News22 hours agoState government renews national demand for health funding